PATENT CLAIM ANALYSIS

Application Number: 15999547
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-08
Patent Classification: ["424", "059000"]

Abstract:
Naphthalimide compounds as used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bone tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabiliation of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Claim (Index 11):
The method of  claim 8 , wherein the pharmaceutically acceptable salt of the component of formula (II) is delivered to a treatment site of the arterial vessel.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.54878
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15815855', '13547196', '14843586', '10982197', '12407481']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8301776393176225
- 35 USC 102 Novelty (BERT): 0.5879916942391532
- Combined Prediction Score: 0.8059590448097755
- Mean Citation Score: 524.777944
- Max Citation Score: 586.4083
- Similarity Product: 402.3443851428746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test